29 Jun 2011

TORONTO: OGRYZLO LECTURE AETIOLOGY of RA. Prof.L.KLARESKOG

"Origins and Outcomes of Rheumatoid Arthritis: Molecular  Mechanisms of a Complex Disease"

by Prof LARS KLARESKOG. Professor and Chairman of the Rheumatology Clinic and Rheumatology Research Unit, Karolinska Institutet and Karolinska Hospital, Stockholm
Thursday, 12th February 2009 at 6pm in the Durkan Lecture Theatre,Institute of Molecular Medicine, Trinity Centre, St James's Hospital, Dublin 8. Please view the flyer

Prof KlareskogQuickTime Podcast of Lecture (audio and powerpoint .mov 496 MB) (to download Quicktime application click here)
Podcast of Lecture (audio and powerpoint mPEG4 92 MB) (to download iTunes application click here) This file is formatted for an ipod or similar size displays and is not suitable for larger displays.
Video of the lecture (Windows Media Player 10 MB)
Brief Biography

Lars Klareskog
has had a long standing interest in the Genetics and Immunology of Rheumatoid Arthritis. He is a medical graduate of Uppsala Unversity where he became Professor and Chairman of the Clinical Immunology Department in 1990. In 1993 he was appointed the Professor and Chairman of the Rheumatology Clinic and Rheumatology Research Unit, at the Karolinska Institutet and Karolinska Hospital, Stockholm. He is a member of the Nobel Assembly at the Karolinska Institute since 1995 and a past member of the Nobel Committee and has acted as the Chairman of the Scientific Board of the Swedish Rheumatism Association since 1997. 
He serves on the editorial boards of numerous journals including Arthritis & Rheumatism; Annals of Rheumatic Diseases; Arthritis Research and Therapy; Current Opinion in Rheumatology; Rheumatology. He has received international acclaim for his research in rheumatology including the The Dutch Rheumatology Society International Prize for Rheumatology research Jaan van Bremer medal ; Hasinger prize of the German Rheumatism Center, and the Wyeth Rheumatology Prize. Lars has a highly active research group and has published over 300 articles in leading journals including Nature Genetics, New England Journal of Medicine and Nature.